The US Food and Drug Administration (USFDA) has taken the action after conducting an inspection of the formulations plant in March this yea...

While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid.

SAIL posted a consolidated net loss of Rs 1,226.47 crore for the first quarter ended June 30, mainly on account of reduced income.

In a BSE filing, Indoco Remedies announced receipt of approval for its abbreviated new drug application (ANDA) for Olanzapine Tablets USP i...

Pharma firm Zydus Cadila today said it has received final approvals from the US health regulator to market four generic products in America.

According to FDA, "Class-III" classification which was described as "a situation in which use of or exposure to a violative product is not ...

Torrent Pharma Inc, a US subsidiary of Ahmedabad-based Torrent Pharma is recalling anti-psychotic drug Olanzapine 10 mg tablets from the US...

Jubilant Life Sciences said it has received approvals from the US health regulator for 4 products that target CNS and CVS therapeutic areas.

Sun Pharmaceutical Industries said it has received approval from the US health regulator for its generic Zyprexa Zydis tablets in the Ameri...

Ranbaxy has received necessary regulatory approvals from the Spanish health authorities to manufacture and market Olanzapine in Spain.